Vijaya Diagnostic Centre Limited (NSE: VIJAYA, BSE: 543350) is a Hyderabad, Telangana-based company in the Medical Diagnostic Centres industry. With a market capitalisation of ₹14,665 Cr, it ranks #471 by market cap among the 6,197 Indian listed companies on FinBizNet, and #2 of 18 in Medical Diagnostic Centres. At ₹1,410.00 (as of 16 Nov 2026), the share price is 11.5% below its 52-week high of ₹1,593.60 and 66.3% above its 52-week low of ₹848.00. The share price is up 38.5% over one year and down 5.1% over three months.
| Current Price | ₹1,410.00 |
|---|---|
| Market Cap | ₹14,665 Cr |
| NSE Symbol | VIJAYA |
| BSE Code | 543350 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Services > Medical Diagnostic Centres |
| P/E Ratio | 84.3 |
| Return on Equity | 19.70% |
| Return on Assets | 11.02% |
| 52-Week Range | ₹848.00 – ₹1,593.60 |
| 1-Year Price Change | +38.5% |
| 3-Month Price Change | -5.1% |
| Beta (1Y) | 0.8 |
| Dividend Yield | 0.14% |
| Headquarters | Hyderabad, Telangana |
| Website | www.vijayadiagnostic.com |
| Revenue | ₹255 Cr |
|---|---|
| Net Profit | ₹59 Cr |
| Net Margin | 23.3% |
| EPS (Basic) | ₹5.78 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Vijaya Diagnostic Centre Limited reported revenue of ₹255 Cr in Q2 FY27, up 26.7% from ₹202 Cr in Q2 FY26 and up 10.6% from ₹231 Cr in Q1 FY27. It posted a net profit of ₹59 Cr for the quarter, against a net profit of ₹43 Cr in Q2 FY26 (up 37.4%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹173 Cr (Q4 FY25) to ₹255 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹255 Cr | ₹59 Cr | 23.3% |
| Q1 FY27 | ₹231 Cr | ₹53 Cr | 23.0% |
| Q4 FY26 | ₹219 Cr | ₹48 Cr | 21.8% |
| Q3 FY26 | ₹205 Cr | ₹43 Cr | 21.0% |
| Q2 FY26 | ₹202 Cr | ₹43 Cr | 21.5% |
| Q1 FY26 | ₹188 Cr | ₹39 Cr | 20.5% |
| Q4 FY25 | ₹173 Cr | ₹35 Cr | 20.1% |
Consolidated figures (₹ crore, XBRL filings).
Promoters held 52.46% of Vijaya Diagnostic Centre Limited's shares as of Sept 2026, against 52.60% in Sept 2025 (−0.14 percentage points). Delivery averaged 47.5% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).
Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. It also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyderabad, India.
1. Diagnostic Services-This segment offers diagnostic services.
1. Diagnostic Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Dr. Lal Pathlabs Ltd | ₹33,934 Cr | 66.4 | 21.48% | ₹874 Cr | +28.7% |
| Vijaya Diagnostic Centre Limited | ₹14,665 Cr | 84.3 | 19.70% | ₹255 Cr | +38.5% |
| Metropolis Healthcare Limited | ₹11,952 Cr | 61.5 | 13.37% | ₹497 Cr | +14.9% |
| Throcare Technologies Ltd | ₹7,764 Cr | 47.6 | 28.74% | ₹271 Cr | +7.5% |
| SURAKSHA DIAGNOSTIC LIMITED | ₹1,856 Cr | 55.4 | 13.84% | ₹99 Cr | +6.9% |
| Krsnaa Diagnostics Ltd | ₹1,625 Cr | 16.8 | 10.89% | ₹271 Cr | -27.0% |
| Gaudium IVF and Women Health Limited | ₹803 Cr | 27.4 | 16.08% | ₹37 Cr | — |
| Chandan Healthcare Limited | ₹582 Cr | 21.9 | 18.43% | ₹81 Cr | — |
| Aspira Pathlab & Diagnostics Ltd | ₹127 Cr | 2,360 | — | — | +115.2% |
Listed by market capitalisation. Ratios are shown for context only.
Vijaya Diagnostic Centre Limited is trading at ₹1,410.00, with a market capitalisation of ₹14,665 Cr.
Vijaya Diagnostic Centre Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Medical Diagnostic Centres).
Vijaya Diagnostic Centre Limited has a P/E of 84.3 and a return on equity of 19.70%.
Vijaya Diagnostic Centre Limited is listed on the NSE under the symbol VIJAYA and on the BSE under the scrip code 543350.
Vijaya Diagnostic Centre Limited's share price is up 38.5% over one year and down 5.1% over three months. Its 52-week range is ₹848.00 to ₹1,593.60.
In Q2 FY27, Vijaya Diagnostic Centre Limited reported revenue of ₹255 Cr and net profit of ₹59 Cr, with basic EPS of ₹5.78 (consolidated, parsed from the company's exchange filing).
Vijaya Diagnostic Centre Limited reported revenue of ₹255 Cr in Q2 FY27, up 26.7% from ₹202 Cr in Q2 FY26 and up 10.6% from ₹231 Cr in Q1 FY27.
Promoters held 52.46% of Vijaya Diagnostic Centre Limited's shares as of Sept 2026, against 52.60% in Sept 2025 (−0.14 percentage points).
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.